Comparison of adverse events between cluster and conventional immunotherapy for allergic rhinitis patients with or without asthma: A systematic review and meta-analysis
American Journal of Otolaryngology - Head and Neck Medicine and Surgery Aug 13, 2019
Jiang Z, et al. - Researchers conducted this systematic review and meta-analysis to ascertain if cluster schedule leads to a higher risk of local adverse reactions (LARs) and systemic adverse reactions (SARs) than cluster schedule does. The meta-analysis included five observational studies and six interventional studies. No differences were found between the cluster and conventional schedules when analyzing SARs by the number of patients, delayed SARs, grade 2 SARs and LARs. In observational studies, analyzes of SARs by injection, grade 1 SARs and LARs by injection showed that cluster schedule had a lower risk of adverse events than conventional schedule. For AR patients with or without asthma, cluster schedule is as safe as or even safer compared with conventional schedule.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries